Abstract: The present invention relates to a process for making a compound of structure 4
which comprises reacting a compound of structure 1 with vinyl sulfone in the presence of a Lewis-acid at a temperature in a range of from 40° C. to 170° C., wherein each R1 is independently H, fluoro, chloro or bromo.
Abstract: The present invention provides a compound of formula I
which is useful as antiviral agents, in particular, as agents against viruses of the herpes family.
Type:
Grant
Filed:
June 22, 2001
Date of Patent:
May 4, 2004
Assignee:
Pharmacia & Upjohn Company
Inventors:
Mark E. Schnute, Valerie A. Vaillancourt
Abstract: The present invention discloses disubstiuted 4-oxo-1,4-dihydro-3-quinolinecarboxamide derivatives. The compounds are useful as antiviral agents, in particular, as agents against viruses of the herpes family.
Abstract: A compound of formula III:
or a pharmaceutically acceptable salt thereof wherein, the variables are as in the specification is provided. The compounds are particularly effective in the treatment or prevention of herpes viruses.
Type:
Grant
Filed:
May 20, 2002
Date of Patent:
February 17, 2004
Assignee:
Pharmacia & Upjohn Company
Inventors:
Valerie A. Vaillancourt, Atli Thorarensen
Abstract: The present invention provides a compound of formula I
or a pharmaceutically acceptable salt thereof wherein R1 and R2 are as defined in the specification. The compounds are useful for the treatment of viral infections.
Type:
Grant
Filed:
December 19, 2002
Date of Patent:
February 3, 2004
Assignee:
Pharmacia & Upjohn Company
Inventors:
Joseph Walter Strohbach, Steven P. Tanis, Malcolm Wilson Moon
Abstract: The present invention relates to a method for selecting an anti-herpes viral compound and a method for selectively inhibiting herpesvrus in a human host in need of such treatment. The present invention relates to a method for selecting an anti-herpes viral compound and a method for selectively inhibiting herpesvrus in a human host in need of such treatment.
Type:
Grant
Filed:
July 12, 2001
Date of Patent:
January 27, 2004
Assignee:
Pharmacia & Upjohn Company
Inventors:
Fred L. Homa, Michael W. Wathen, Todd A. Hopkins, Darrell R. Thomsen
Abstract: The present invention provides a compound of formula I
which is useful as antiviral agents, in particular, as agents against viruses of the herpes family.
Type:
Grant
Filed:
November 5, 2002
Date of Patent:
January 27, 2004
Assignee:
Pharmacia and Upjohn Comapny
Inventors:
Valerie A. Vaillancourt, Sandra Staley, Audris Huang, Richard Allen Nugent, Ke Chen, Sajiv K. Nair, James A. Nieman, Joseph Walter Strohbach
Abstract: The present invention provides a compound of formula I
which is useful as antiviral agents, in particular, as agents against viruses of the herpes family.
Type:
Grant
Filed:
June 28, 2001
Date of Patent:
January 6, 2004
Assignee:
Pharmacia & Upjohn Co.
Inventors:
Steven Ronald Turner, Suvit Thaisrivongs, Atli Thorarensen
Abstract: The present invention provides compounds of formula I
which are useful as antiviral agents, in particular, as agents against viruses of the herpes family.
Abstract: The present invention provides a compound of formula I
which is useful as antiviral agents, in particular, as agents against viruses of the herpes family.
Type:
Grant
Filed:
June 22, 2001
Date of Patent:
September 23, 2003
Assignee:
Pharmacia & Upjohn Company
Inventors:
David John Anderson, Gordon L. Bundy, Fred L. Ciske, David R. Graber, Michael J. Genin, Thomas M. Judge, Malcolm Wilson Moon, Mark E. Schnute, Joseph Walter Strohbach, Suvit Thaisrivongs, Atli Thorarensen, Steven Ronald Turner, Valerie A. Vaillancourt, Allison J. Wolf
Abstract: The present invention provides a compound of formula I
which is useful as antiviral agents, in particular, as agents against viruses of the herpes family.
Abstract: Oxazolidinones and methods for their synthesis are provided. Also provided are combinatorial libraries comprising oxazolidinones, and methods to prepare the libraries. Further provided are methods of making biologically active oxazolidinones as well as pharmaceutically acceptable compositions comprising the oxazolidinones. The methods of library preparation include the attachment of oxazolidinones to a solid support. The methods of compound preparation in one embodiment involve the reaction of an iminophosphorane with a carbonyl containing polymeric support.
Type:
Grant
Filed:
December 28, 2001
Date of Patent:
May 13, 2003
Assignee:
Pharmacia & Upjohn Company
Inventors:
Mikhail F. Gordeev, Gary W. Luehr, Dinesh V. Patel, Zhi-Jie Ni, Eric Gordon
Abstract: The present invention provides a compound of formula I
which is useful as antiviral agents, in particular, as agents against viruses of the herpes family.
Type:
Grant
Filed:
June 22, 2001
Date of Patent:
May 6, 2003
Assignee:
Pharmacia & Upjohn Company
Inventors:
Fred L. Ciske, Michael J. Genin, Byung Hyun Lee, Mark E. Schnute, Valerie A. Vaillancourt
Abstract: The present invention discloses disubstiuted 4-oxo-1,4-dihydro-3-quinolinecarboxamide derivatives. The compounds are useful as antiviral agents, in particular, as agents against viruses of the herpes family.
Type:
Grant
Filed:
February 27, 2002
Date of Patent:
April 8, 2003
Assignee:
Pharmacia & Upjohn Company
Inventors:
Valerie A. Vaillancourt, Joseph Walter Strohbach, Audris Huang
Abstract: The present invention provides compounds of Formula 1
or pharmaceutical acceptable salts thereof wherein A, G and R1 are as defined in the claims which are antibacterial agents.
Type:
Grant
Filed:
March 30, 2001
Date of Patent:
March 25, 2003
Assignee:
Pharmacia & Upjohn Company
Inventors:
Jackson B. Hester, Jr., Eldon George Nidy, Salvatore Charles Perricone, Toni-Jo Poel
Abstract: Oxazolidinones and methods for their synthesis are provided. Also provided are combinatorial libraries comprising oxazolidinones, and methods to prepare the libraries. Further provided are methods of making biologically active oxazolidinones as well as pharmaceutically acceptable compositions comprising the oxazolidinones. The methods of library preparation include the attachment of oxazolidinones to a solid support. The methods of compound preparation in one embodiment involve the reaction of an iminophosphorane with a carbonyl containing polymeric support.
Type:
Grant
Filed:
August 30, 2000
Date of Patent:
March 11, 2003
Assignee:
Pharmacia & Upjohn Company
Inventors:
Mikhail F. Gordeev, Gary W. Luehr, Dinesh V. Patel, Zhi-Jie Ni, Eric Gordon
Abstract: The present invention provides a novel pharmaceutical composition based on the use of a particular oil phase which comprises a lipophilic, pharmaceutically active agent, a mixture of diglyceride and monoglyceride in a ratio of from about 9:1 to about 6:4 by weight (diglyceride:monoglyceride) wherein the diglyceride and monoglyceride are mono- or di- unsaturated fatty acid esters of glycerol having sixteen to twenty-two carbon chain length, one or more pharmaceutically acceptable solvents, and one or more pharmaceutically acceptable surfactants. The composition is in a form of self-emulsifying formulation which provides high concentration and high oral bioavailability for lipophilic compounds.